|Bid||89.80 x 800|
|Ask||91.69 x 800|
|Day's range||89.06 - 91.54|
|52-week range||86.95 - 135.89|
|Beta (5Y monthly)||0.75|
|PE ratio (TTM)||24.50|
|Forward dividend & yield||2.72 (2.98%)|
|Ex-dividend date||23 June 2022|
|1y target est||N/A|
Medtronic plc (NYSE: MDT) today announced that its Board of Directors appointed Lidia Fonseca, Executive Vice President, Chief Digital and Technology Officer at Pfizer, to the Board as an independent director, effective June 27, 2022. Ms. Fonseca will serve on the Compensation Committee and Science and Technology Committee of the Board.
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual Goldman Sachs global healthcare conference on Tuesday, June 14, 2022.
Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2022, which ended April 29, 2022.